Dr. A K Singh is a renowned endocrinologist practicing at G.D Hospital & Diabetes Institute, Kolkata and Sun Valley Diabetes Research Centre & Hospital, Guwahati. He is a Speaker and Chair of Association of Physician of India, Research Society of studies in Diabetes in India and Endocrine Society of India. He is a Principal Investigator in Phase 3/4 trials. He has around 75 publications. There are many recent advances associated with the oral drugs for diabetes management. The CAROLINA trial has provided robust proof that two commonly prescribed drugs, linagliptin and glimepiride, can continue to be used for the benefit of persons with diabetes.
In this session Dr. A K Singh emphasizes about the effects of various new oral drugs for the treatment of T2DM.
0 Comments